Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist (OASE Melanome)
Patients at Risk for Melanoma
About this trial
This is an interventional prevention trial for Patients at Risk for Melanoma focused on measuring Public Health, General Medicine, Dermatology
Eligibility Criteria
Inclusion Criteria:
Patients:
- Consulting a general practitioner participating in the study,
- Having a suspicious cutaneous lesion of melanoma according to the MG,
- Referred to a dermatologist who agreed to participate in the study,
- > = 18 years of age, with written informed consent,
- Affiliated to a social security scheme
Exclusion Criteria:
Patients:
- Consulting a general practitioner who does not participate in the study,
- Having no suspect melanoma lesion according to MG,
- Referred to the dermatologist for symptoms or pathologies unrelated to a suspicion of melanoma
- Wishing to consult a dermatologist who refused to participate in the study,
- Refusing the transmission by mail of 2 anonymised photos,
- <18 years of age, or with no written informed consent.
- Major under tutelage, under curatorship
Sites / Locations
- University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group
Control group
General practitioners will be invited to screen for melanoma as part of their regular consultations. The MG collects relevant clinical information The MG takes 2 photographs of the lesion with his smartphone. The MG sends to the dermatologist by e-mail the 2 photographs of the lesion accompanied by relevant clinical information The MG calls the secretariat of the dermatologist to record the admissibility of the mail, to give the identity and the coordinates of the patient whose photos have just been sent and to obtain an appointment. The dermatologist proposes an appointment to the patient.
General practitioners will be invited to screen for melanoma as part of their regular consultations. General practitioners and dermatologists continue their practice in the usual way.